Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monitor: molecules and profiles.

M A. Walker1, D Barlocco

  • 1Bristol-Myers Squibb, Pharmaceutical Research Institute, 06492, tel: +1 203 677 6686, fax: +1 203 677 7702, Wallingford, CT, USA

Drug Discovery Today
|March 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designed multiple ligands: basic research vs clinical outcomes.

Current medicinal chemistry·2012
Same author

Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.

Current medicinal chemistry·2008
Same author

Thymidylate synthase structure, function and implication in drug discovery.

Current medicinal chemistry·2005
Same author

Semicarbazide-sensitive amine oxidase: current status and perspectives.

Current medicinal chemistry·2004
Same author

Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs.

Mini reviews in medicinal chemistry·2003
Same author

Characterization and pharmacological actions of tecostanine, an alkaloid of Tecoma stans.

Die Pharmazie·2003
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Monitor offers insights into drug discovery advancements, covering new molecules and emerging research. It highlights chemical, pharmacological, and biological significance, alongside novel technologies and legislative updates.

Area of Science:

  • Drug Discovery
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Monitor journal provides updates on drug discovery.
  • Covers recent presentations and publications.
  • Includes expert commentaries on emerging technologies.

Purpose of the Study:

  • To offer insights into the latest developments in drug discovery.
  • To summarize new molecules and their significance.
  • To provide commentary on research, targets, and technologies.

Main Methods:

  • Synopsis of recent presentations and publications.
  • Expert commentaries on technologies.
  • Summarization of new molecules' chemistry and pharmacology.

Main Results:

Related Experiment Videos

  • Highlights new molecules with pharmacological significance.
  • Discusses biological relevance of reported molecules.
  • Covers emerging research, molecular targets, and novel technologies.

Conclusions:

  • Monitor serves as a resource for drug discovery professionals.
  • Provides a comprehensive overview of the field.
  • Keeps readers informed on advancements and challenges.